Dowling & Yahnke’s Panacea Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class PANA.WS Stock Holding History

Dowling & Yahnke’s Portfolio PANA.WS Stock Details PANA.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-11,063	Closed	-$35K	–	344
2020 Q4	$35K	Hold	11,063	–	–	﹤0.01%	326
2020 Q3	$26K	Buy	+11,063	New	+$27.6K	﹤0.01%	306

Dowling & Yahnke's PANA.WS Position: Q1 2021 in Review

Dowling & Yahnke sold out of Panacea Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class (PANA.WS) in Q1 2021, closing a stake of 11,063 shares — an estimated $35K sold.

Dowling & Yahnke first reported a position in PANA.WS in Q3 2020 and held it in 2 quarters. The position peaked at $35K in Q4 2020. 0 funds tracked by Wall St. Rank hold PANA.WS as of Q1 2021.

Dowling & Yahnke reported no remaining Panacea Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class position as of Q1 2021 after selling out during the quarter.
Dowling & Yahnke sold 11,063 Panacea Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class shares in Q1 2021, an estimated $35K.
Dowling & Yahnke first reported a position in Panacea Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class in Q3 2020 and held it in 2 quarters.
Dowling & Yahnke's Panacea Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class position peaked at $35K in Q4 2020.
0 funds tracked by Wall St. Rank held Panacea Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class as of Q1 2021.

Based on Dowling & Yahnke's 13F filing for Q1 2021, filed 29 Apr 2021.